| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SELLAS Life Sciences Group, Inc. | Chief Commercial Officer | Common Stock | 40,918 | $255,774 | $6.25 | 22 Jan 2024 | Direct |
| SELLAS Life Sciences Group, Inc. | Chief Commercial Officer | Class A Common Stock | 20,918 | $22,591 | $1.08 | 06 Dec 2023 | Direct |
| SELLAS Life Sciences Group, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 30,000 | 22 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLS | SELLAS Life Sciences Group, Inc. | 22 Jan 2024 | 2 | $0 | 4 | Chief Commercial Officer | 25 Jan 2024, 06:02 |
| SLS | SELLAS Life Sciences Group, Inc. | 06 Dec 2023 | 1 | -$1,169 | 4 | Chief Commercial Officer | 08 Dec 2023, 16:10 |
| SLS | SELLAS Life Sciences Group, Inc. | 02 Feb 2023 | 2 | $0 | 4 | Chief Commercial Officer | 03 Feb 2023, 16:14 |
| SLS | SELLAS Life Sciences Group, Inc. | 14 Mar 2022 | 1 | $0 | 4 | Chief Commercial Officer | 15 Mar 2022, 16:05 |
| SLS | SELLAS Life Sciences Group, Inc. | 14 Mar 2022 | 0 | $0 | 3 | Chief Commercial Officer | 14 Mar 2022, 16:19 |